Skip to content

Precigen PGEN Total Operating Expenses

Total Operating Expenses at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$116.31M+23.8%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$82.77M+31.2%
Arrowhead Research logo
Arrowhead ResearchARWR
$215M+33.1%
PVL
Palvella TherapeuticsPVLA
$14.86M+88.7%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$131.71M-11.8%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's total operating expenses?
Precigen (PGEN) reported total operating expenses of $29.25M in Q1 2026.
How has Precigen's total operating expenses changed year-over-year?
Precigen's total operating expenses increased by 22.2% year-over-year, from $23.94M to $29.25M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.